The "Enterprise Tech Ecosystem Series: Almirall - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report provides insights into the Almirall's tech activities, including ...

Almirall’s 16th Skin Academy is a unique opportunity for collaboration in medical dermatology as it brings together leading experts from across the globe to advance science and innovative approaches ...

As of 10:24:48 a.m. GMT. Market Open. ORLANDO, Fla., March 07, 2025--Almirall, S.A. (ALM), a global pharmaceutical company dedicated to medical dermatology presents five scientific posters at the 2025 ...

Jefferies analyst Lucy Codrington maintained a Buy rating on Almirall (0O9B – Research Report) yesterday and set a price target of €17.00. The company’s shares closed yesterday at €9.86.

Almirall´s strong presence at the AAD conference, sharing new data on Almirall’s dermatology and pipeline portfolio demonstrate its dedication to the medical community and patients living with ...